The Swiss drug company Roche will launch an OA database for its clinical drug trial data. From the company press release (January 21): 'Roche announced today that it is establishing a global clinical trial protocol registry to disclose information about new Phase II to Phase IV studies at or before their start. In addition, the company will create a global clinical trial results database for key results from completed trials. The new registry and results database will enable the coordination of data Roche publishes and ensure that ultimately, there is one global source for all Roche-sponsored clinical trial data. Both the clinical trial registry and results database, which will be hosted by an independent, neutral entity, will be available to the public via a website by the end of the first quarter 2005. The name of the organisation will be announced in due time....The Roche approach is in accord with and even exceeds the information disclosure principles published earlier this year by the European Federation of Pharmaceutical Industry Associations (EFPIA).'
Posted by
Peter Suber at 1/26/2005 08:19:00 AM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
